MDMA-assisted psychotherapy would result significantly more cost-effective than current available treatment options for post-traumatic stress disorder, according to a study distributed by the Multidisciplinary Association for Psychedelic Studies.
The peer-reviewed study, published Tuesday in the research journal PLOS ONE, uses a decision-analytic model to portray the costs and health benefits of treating chronic PTSD patients with MDMA-assisted psychotherapy, and compares the results to a control group.
“MDMA-assisted psychotherapy is conducted by a licensed psychologist and trained clinician over the course of 12 sessions with three sessions lasting six or more hours. The cost of that time is not inconsiderable, but in just over three years, health care providers will break even on the costs of mental health and general medical care,” said the study’s lead author Elliot Marseille.
The researchers conclude that using MDMA-assisted psychotherapy in 1,000 patients with PTSD would reduce general and mental …